Literature DB >> 30280947

Site specific hypermethylation of CpGs in Connexin genes 30, 26 and 43 in different grades of glioma and attenuated levels of their mRNAs.

Jayalakshmi J1, Arambakkam Janardhanam Vanisree1, Shantha Ravisankar2, Rama K3.   

Abstract

AIM: Gliomas, the intracranial tumours are considered the deadliest malignancies. The gap junctional Connexins (Cxs) that maintain cellular homeostasis perform a unique function in glial tumour suppression. However, the differential methylation patterns of Cxs were not revealed in glioma so far. The current study attempts to categorise promoter methylation of Cx30 and Cx26 and intron methylation of Cx43 in different grades of human glioma.
MATERIALS AND METHODS: About 85 glioma patients with pathologically confirmed grades and 15 control brain tissues were recruited in the study. Bisulphite-PCR-Single Stranded Conformation analysis(SSCA), Bisulphite sequencing and MeDIP-qPCR were carried out to assess methylation status and Cx mRNA levels were also analysed to evaluate the effect of methylation.
RESULTS: We found that promoter CpG islands(CpGs) reside in Sp1 and Ap2 sites of Cx30 and 26 were hypermethylated in high grades (HG) of glioma rather than low grades. The input % of both was significantly increased (p < 0.03) in progressive grades. Interestingly, Cx43 could exhibit a significant increase (p < 0.05) in input % only in grade IV. While, Cx30 and 26 mRNAs were downregulated according to their methylation status in progressive fashion with grades, Cx43 was downregulated irrespective of intron methylation.
CONCLUSION: Thus, we suggest that the sites and extent of methylation of Cxs (30 and 26 but not in 43) are found to be altered. In different grades of glioma can provide better appreciation of the grade of the patient and might help in strategies based on epigenetic approaches.

Entities:  

Keywords:  Bisulphite sequencing; Connexin; CpG Island; MeDIP; methylation

Mesh:

Substances:

Year:  2018        PMID: 30280947     DOI: 10.1080/00207454.2018.1526802

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  2 in total

1.  Activin/Nodal/TGF-β Pathway Inhibitor Accelerates BMP4-Induced Cochlear Gap Junction Formation During in vitro Differentiation of Embryonic Stem Cells.

Authors:  Ichiro Fukunaga; Yoko Oe; Cheng Chen; Keiko Danzaki; Sayaka Ohta; Akito Koike; Katsuhisa Ikeda; Kazusaku Kamiya
Journal:  Front Cell Dev Biol       Date:  2021-04-21

Review 2.  Role of Connexins 30, 36, and 43 in Brain Tumors, Neurodegenerative Diseases, and Neuroprotection.

Authors:  Oscar F Sánchez; Andrea V Rodríguez; José M Velasco-España; Laura C Murillo; Jhon-Jairo Sutachan; Sonia-Luz Albarracin
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.